Your trusted source for investing success

Tag: lead

5 Top Biotech Stocks on the TSX Year-to-date

5 Top Biotech Stocks on the TSX Year-to-date

The biotech sector has steadily enjoyed an increase this year, in part thanks to significant advancements and in spite of the uncertainty from the White House as the proposal of a new healthcare bill holds the grip of most life science markets.

MYM Enters Into Consulting Agreement with Leading Cannabis Industry Legal Experts – International Cannabis Consultants Co.

MYM Enters Into Consulting Agreement with Leading Cannabis Industry Legal Experts – International Cannabis Consultants Co.

MYM Nutraceuticals Inc., (CSE: MYM) (the “Company” or “MYM”)  is pleased to announce that it has entered into a consulting agreement with International Cannabis Consultants Co. (“Incanco”), leading authorities on the legal framework of cannabis legislation in Canada. Incanco’s Chief Operating Officer, John Conroy, has been a trailblazer in effecting groundbreaking

Hannan Drills 4.0 Metres @ 0.7% Zinc, 8.9% Lead and 31 G/t Silver (8.6% ZnEq) in First Step-out Hole at Kilbricken, Ireland

Hannan Drills 4.0 Metres @ 0.7% Zinc, 8.9% Lead and 31 G/t Silver (8.6% ZnEq) in First Step-out Hole at Kilbricken, Ireland

Hannan Metals (TSXV:HAN) is pleased to announce drill results from the second hole completed in its resource expansion program at the 100%-owned Kilbricken zinc-lead-silver-copper deposit in County Clare, Ireland.  Thirteen holes are planned in this 8,500 metre drill program, scheduled to be completed during the first quarter of 2018.

Key Points:

Significant mineralization was

DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer

DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development of new cancer therapies, today announced that the U.S. Food and Drug Administration (“FDA”) has allowed an additional Investigational New Drug Application (“IND”) to study its lead drug candidate VAL-083 as a potential treatment for ovarian cancer.

 “The opening of this

Adventus Zinc Enters Into Option Agreement With Salazar Resources on the Curipamba Copper-Zinc-Gold Project and Forms Exploration Alliance in Ecuador

Adventus Zinc Corporation (“Adventus”) (TSX VENTURE:ADZN) and Salazar Resources Limited (“Salazar”) (TSX VENTURE:SRL) are pleased to announce that they have entered into a definitive option agreement (the “Option”) whereby Adventus may earn a 75% interest in Salazar’s Curipamba Project (the “Project”) located in Ecuador by funding exploration and development expenditures

Connect with our Featured Silver Stocks to receive the latest news and investor presentations.

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
5 Top Biotech Stocks on the TSX Year-to-date

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/top-biotech-stocks-tsx/